Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8659 |
High Similarity |
NPD3818 |
Discontinued |
0.8645 |
High Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.8553 |
High Similarity |
NPD2801 |
Approved |
0.8447 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8405 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8344 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.8333 |
Intermediate Similarity |
NPD4966 |
Approved |
0.8333 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.8333 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.8333 |
Intermediate Similarity |
NPD4965 |
Approved |
0.8263 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8261 |
Intermediate Similarity |
NPD37 |
Approved |
0.8261 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8225 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8193 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8187 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8166 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8133 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.8118 |
Intermediate Similarity |
NPD7472 |
Approved |
0.811 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8098 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8061 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8059 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8046 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.8036 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.8026 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7987 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7977 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7965 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7939 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7935 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7922 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7919 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7888 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7885 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7882 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7882 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7882 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7879 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7826 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7824 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7816 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7811 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7805 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7792 |
Intermediate Similarity |
NPD943 |
Approved |
0.7785 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7742 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7716 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7716 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7716 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7714 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7688 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7688 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7673 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7665 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7657 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7654 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7644 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7636 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7633 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7614 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7611 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.761 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.761 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7597 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.759 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7588 |
Intermediate Similarity |
NPD919 |
Approved |
0.7576 |
Intermediate Similarity |
NPD1653 |
Approved |
0.756 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7547 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7529 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7527 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7515 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7515 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7514 |
Intermediate Similarity |
NPD5242 |
Approved |
0.75 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7486 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD7028 |
Phase 2 |
0.7469 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7468 |
Intermediate Similarity |
NPD9494 |
Approved |
0.744 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7436 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7434 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7407 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7405 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7403 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7396 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7391 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7386 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7375 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7375 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7333 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7329 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7329 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7317 |
Intermediate Similarity |
NPD6190 |
Approved |
0.731 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7308 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7305 |
Intermediate Similarity |
NPD920 |
Approved |
0.7299 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7296 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7273 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7267 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7257 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7256 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7255 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.725 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7249 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7249 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7249 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7249 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7249 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7249 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7249 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7244 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7235 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7235 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7233 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7233 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7219 |
Intermediate Similarity |
NPD9268 |
Approved |
0.7215 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7212 |
Intermediate Similarity |
NPD2309 |
Approved |
0.72 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7196 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7195 |
Intermediate Similarity |
NPD1243 |
Approved |
0.719 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7186 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7173 |
Intermediate Similarity |
NPD5006 |
Approved |
0.7173 |
Intermediate Similarity |
NPD5005 |
Approved |
0.7159 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7159 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7159 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7143 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7143 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7143 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7143 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7135 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7135 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7135 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7135 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7135 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7134 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.712 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7118 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7107 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7101 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7098 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7098 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7089 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7088 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7083 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7073 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7073 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7072 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7068 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7066 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7056 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7053 |
Intermediate Similarity |
NPD4420 |
Approved |
0.7051 |
Intermediate Similarity |
NPD1876 |
Approved |
0.7047 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7041 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7025 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7024 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7011 |
Intermediate Similarity |
NPD5977 |
Approved |
0.7011 |
Intermediate Similarity |
NPD5978 |
Approved |
0.7006 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.6995 |
Remote Similarity |
NPD7549 |
Discontinued |
0.6995 |
Remote Similarity |
NPD6823 |
Phase 2 |
0.699 |
Remote Similarity |
NPD7701 |
Phase 2 |
0.6988 |
Remote Similarity |
NPD2654 |
Approved |
0.6987 |
Remote Similarity |
NPD2983 |
Phase 2 |
0.6987 |
Remote Similarity |
NPD2982 |
Phase 2 |
0.6984 |
Remote Similarity |
NPD6535 |
Approved |
0.6984 |
Remote Similarity |
NPD6534 |
Approved |
0.6983 |
Remote Similarity |
NPD2403 |
Approved |
0.6982 |
Remote Similarity |
NPD5401 |
Approved |
0.6975 |
Remote Similarity |
NPD6355 |
Discontinued |
0.697 |
Remote Similarity |
NPD7801 |
Approved |
0.697 |
Remote Similarity |
NPD2346 |
Discontinued |
0.6968 |
Remote Similarity |
NPD1610 |
Phase 2 |
0.6948 |
Remote Similarity |
NPD17 |
Approved |
0.6946 |
Remote Similarity |
NPD4110 |
Phase 3 |
0.6946 |
Remote Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.6946 |
Remote Similarity |
NPD7003 |
Approved |
0.6928 |
Remote Similarity |
NPD9545 |
Approved |
0.6923 |
Remote Similarity |
NPD2981 |
Phase 2 |
0.6919 |
Remote Similarity |
NPD7874 |
Approved |
0.6919 |
Remote Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.691 |
Remote Similarity |
NPD8127 |
Discontinued |
0.6899 |
Remote Similarity |
NPD1203 |
Approved |
0.6894 |
Remote Similarity |
NPD2313 |
Discontinued |
0.6883 |
Remote Similarity |
NPD1357 |
Approved |
0.6875 |
Remote Similarity |
NPD5019 |
Clinical (unspecified phase) |
0.6875 |
Remote Similarity |
NPD7700 |
Phase 2 |
0.6875
|
Remote Similarity |
NPD7699 |
Phase 2 |